SBC Medical Group Holdings Incorporated Payments to Fund Long-term Loans to Related Parties
SBC Medical Group Holdings Incorporated (SBC) reported Payments to Fund Long-term Loans to Related Parties of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToFundLongtermLoansToRelatedParties · last filed 2026-03-27
- SBC Medical Group Holdings Incorporated payments to fund long-term loans to related parties for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SBC Medical Group Holdings Incorporated payments to fund long-term loans to related parties for the quarter ending 2024-12-31 was $5.00K, a 99.60% decline year-over-year.
- SBC Medical Group Holdings Incorporated payments to fund long-term loans to related parties for the quarter ending 2024-09-30 was $0.00.
- SBC Medical Group Holdings Incorporated payments to fund long-term loans to related parties for the quarter ending 2024-06-30 was $250.22K.
- SBC Medical Group Holdings Incorporated payments to fund long-term loans to related parties for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- SBC Medical Group Holdings Incorporated payments to fund long-term loans to related parties for fiscal 2024 was $622.80K, a 72.72% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated payments to fund long-term loans to related parties for fiscal 2023 was $2.28M.
| Period end | Payments to Fund Long-term Loans to Related Parties 3 month | Payments to Fund Long-term Loans to Related Parties 6 month | Payments to Fund Long-term Loans to Related Parties 9 month | Payments to Fund Long-term Loans to Related Parties 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 10-K · filed 2026-03-27 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | |||
| 2024-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $5.00K derived: sum of 2 quarters · filed 2026-03-27 | $255.22K derived: sum of 3 quarters · filed 2026-03-27 | $622.80K 10-K · filed 2026-03-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $250.22K derived: sum of 2 quarters · filed 2025-11-14 | $617.80K 10-Q · filed 2025-11-14 | $1.88M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $250.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $617.80K 10-Q · filed 2025-08-13 | $1.88M derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | $367.58K 10-Q · filed 2025-05-15 | $1.63M derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $2.28M 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $1.02M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |